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An outbreak of dengue fever in Madeira island was 
reported in 2012. Clinical and laboratory findings of 
the first two laboratory-confirmed autochthonous 
cases are reported. Both cases had fever (≥38 °C) 
and petechial rash. Symptoms also included myalgia, 
asthenia, nausea, vomiting, anorexia, diffuse abdomi-
nal pain, and diarrhoea. The two cases were confirmed 
by serology and one tested positive for a dengue viral 
sequence. Dengue virus serotype DEN-1 was identified 
with probable Central or South American origin.
Dengue virus (family Flaviviridae, genus Flavivirus) is 
the aetiological agent of dengue fever, a mosquito-
borne infection endemic in the tropics and subtropics. 
The National Institute of Health Dr. Ricardo Jorge (INSA) 
performs reference laboratory diagnosis of dengue in 
Portugal. Human cases identified annually in this labo-
ratory are imported from endemic areas. In terms of 
number of positive samples, these areas include by 
order of importance, mainly Brazil, but also Timor-
Leste, India, Cape Verde, Mexico, Thailand, Angola, 
Pakistan and Vietnam. In the beginning of October 
2012, for the first time, two autochthonous cases of 
dengue fever from Madeira archipelago, Portugal were 
diagnosed. These signaled the beginning of an out-
break and the latest published data includes 2,144 
reported autochthonous cases of dengue fever in 
Madeira island [1]. Clinical and laboratory findings of 
these first two cases are reported.
Case reports
Case 1 
On 20 September, 2012 a 16 year-old woman developed 
febrile illness with temperature up to 38.5°C, nausea, 
vomiting, anorexia, diffuse abdominal pain and diar-
rhoea. Five days later she presented at the local hos-
pital, with prostration, and, in the second day after 
admission developed petechial rash at the upper and 
lower limbs that spread to the lower abdomen within 
24 hours.
The patient, who lives in Caniço in the neighbourhood 
of the town of Funchal and studies in Funchal, men-
tioned traveling to Algarve, south of mainland Portugal, 
six weeks before and had not been vaccinated against 
flaviviruses such as yellow fever, tick-borne encephali-
tis and Japanese encephalitis viruses.
The first laboratory findings in the hospital 
showed thrombocytopenia with minimal platelet 
count (65x109/L, norm: 150–400x109/L), leucope-
nia (2.4x109/L, norm: 4.5–13.5x109/L) and elevated 
transaminases (alanine/glutamic pyruvic transami-
nase (ALT/GPT): 117U/L, norm: 17–63 U/L; aspartate/
glutamic-oxaloacetic (AST/GOT): 95 U/L, norm: 10–50 
U/L). In the Funchal hospital the screening test for den-
gue was performed by immunochromatography (NADAL 
dengue fever IgG/IgM) followed by dengue IgM and IgG 
capture enzyme-linked immunosorbent assay (ELISA) 
(Panbio). The serum sample taken on day 6 after the 
onset of febrile illness was positive by immunochroma-
tography, ELISA IgM positive (5.91) and IgG negative 
(0.07) (cut-off >1.1).
In the National Institute of Health, sera samples were 
tested by immunofluorescent assay in-house (IgG and 
IgM) and Euroimmun commercial test (IgM). The serum 
sample (day 11 post onset) was positive for dengue 
virus specific IgM with a titre of 256 (cut-off =16) and 
IgG with a titre of 1,024 (cut-off =32). The serum sample 
was also tested for immunoglobulins specific to other 
flaviviruses, such as yellow fever, tick-borne encepha-
litis, West Nile and Japanese encephalitis viruses by 
immunofluorescent assays and all assay results were 
negative. The patient recovered without complications 
and was discharged from the hospital on the eighth 
day of hospitalisation. 
Case 2 
On 27 September 2012, a 44 year-old man developed 
febrile illness with temperature up to 38.0°C, myalgia 
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and asthenia. Two days later he visited the local hospi-
tal and presented also with petechial rash at the upper 
and lower limbs.
The patient who lives and works in Santa Luzia, a local 
administrative unit of the city of Funchal, did not travel 
abroad and reported no vaccination against yellow 
fever, tick-borne encephalitis and Japanese encephali-
tis viruses.
The first laboratory findings in the hospital showed 
thrombocytopenia with minimal platelet count 
(74x109/L, norm: 150–400x109/L),  leucopenia 
(2.7x109/L, norm: 4.5–13.5x109/L), very high creatine 
kinase (CK) (1,146 ng/ml, norm: 20–200 ng/ml), and 
slightly elevated AST/GOT (58 U/L, norm: 10–50 U/L), 
high lactate dehydrogenase (LDH) (395 U/L, norm: <246 
U/L). A sample collected on day 2 post onset was posi-
tive by immunochromatography, ELISA IgM positive 
(5.32), unusually at day 2, and IgG negative (0.18). The 
IgM antibodies in cases of dengue infection are usu-
ally detected after the fifth day following the onset of 
symptoms suggesting that maybe, in this case, the 
date of the onset was not properly determined.
In the National Institute of Health the serum sample 
(day 4 post symptom onset) tested by immunofluores-
cent assay was positive for dengue virus specific IgM 
with a titre of 1,024 (cut-off =16) and IgG with a titre of 
512 (cut-off =32). The serum sample was also subjected 
to immunofluorescent assays for immunoglobulins 
specific to other flaviviruses, such as yellow fever, tick-
borne encephalitis, West Nile and Japanese encephali-
tis viruses and all assay results were negative.
The patient recovered without complications and was 
discharged from the hospital on the fourth day of 
hospitalisation. Twelve days after the onset of symp-
toms he returned for further evaluation, and the blood 
count had returned to normal (leukocytes (7.2x109/L, 
norm: 4.5–13.5x109/L) and platelets (326x109/L, norm: 
150–400x109/L)).
Molecular laboratory analysis
In the National Institute of Health laboratory, nucleic 
acids were extracted from ethylenediaminetetraacetic 
acid (EDTA) blood samples using NucliSens easyMAG 
platform (bioMérieux). The presence of dengue virus 
RNA was checked by one-step conventional reverse 
transcription-polymerase chain reaction (RT-PCR) using 
generic flavivirus primers targeting the non-structural 
protein 5 (NS5) gene [2,3] followed by dengue specific 
assays including multiplex RT-PCR targeting the core-
pre-membrane (CprM) region [4,5] and real time RT-PCR 
[6].
Fragments obtained by nested-PCR (NS5, 163 bp and 
CprM region, 454 bp) were sequenced bi-directionaly. 
The 454 bp CprM partial polyprotein gene sequence 
was deposited on the GenBank database under acces-
sion number KC248375. Similarity searches were made 
within the GenBank data set using the basic local align-
ment search tool (BLAST) BLASTN algorithm [7].
For case 1, RT-PCR for flaviviruses was negative as 
well as the results from both dengue specific assays 
(conventional multiplex and real time RT-PCR) on day 
11 post onset of disease. For case 2, RT-PCR for flavi-
viruses was positive as well as dengue specific real 
time RT-PCR and conventional multiplex RT-PCR on day 
5 post onset.
Four distinct dengue virus serotypes (DEN-1, DEN-
2, DEN-3 and DEN-4) are recognised [8]. Sequence 
Figure
Phylogenetic analysis of a viral sequence derived from an autochthonous case of dengue fever in Madeira, Portugal, October 2012
The phylogeny was inferred based on the core-pre-membrane (CprM) nucleotide sequences (454 bp) by neighbour-joining method using 
molecular evolutionary genetics analysis (MEGA) version 5 software. Distance matrices were calculated using Kimura two-parameter model. 
Bootstrap values obtained from 1,000 replicate trees are shown for key nodes. The sequence derived from the autochthonous case of dengue 
fever in Madeira is highlighted in blue.
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analysis of NS5 and CprM partial sequences derived 
from case 2 by BLASTN and a preliminary phylogenetic 
analysis based on CprM nucleotide sequences ascer-
tain DEN serotype 1 identified as related to viruses cir-
culating in latin America namely Colombia, Venezuela, 
and the Roraima region in northern Brazil [7] (Figure). 
The virus isolated in Madeira is also associated with 
DEN-1 strains recognised as belonging to genotype 
V (e.g. in the Figure, GenBank accession numbers: 
JX502769, JQ015185), a genotype that represents most 
of the strains collected in the Americas, West Africa 
and a limited number of strains collected from Asia [9].
For the case 2, the viral isolation in Vero E6 cells was 
achieved and the full genome sequence is in progress.
Discussion and conclusions
Infection with dengue virus causes a wide spectrum 
of human disease, from asymptomatic infections, to 
classic dengue fever and to haemorrhagic disease. 
More severe disease is usually associated with sec-
ondary infections with heterologous serotypes [10,11]. 
Between early October 2012 and the beginning of 
2013, 2,144 autochthonous dengue virus infections 
were reported in the island of Madeira. There were no 
reports of severe disease and a decrease of new cases 
in the last weeks of 2012 was observed [1].
Dengue virus is transmitted by Aedes mosquitoes, 
namely Aedes (Ae.) aegypti and Ae.  albopictus. 
Ae. aegypti was introduced in Madeira probably from a 
Caribbean country (personal communication, M Melim, 
2009) and its presence was detected for the first time 
in 2005, in the city of Funchal [12]. Although vector con-
trol measures to eradicate or to reduce the spread of 
this invasive mosquito species were taken, it became 
the most abundant mosquito species namely in the 
sites selected for the national vector surveillance pro-
gramme in 2010 and 2011 [13].
The first cases of the dengue fever outbreak in Madeira, 
as the majority of all cases, happened in Funchal, the 
urban environment where the mosquito Ae. aegypti 
was first found [12]. In 2012, the combination of the 
high vector density with multiple breeding sites in the 
city [13] and lack of immunity of the population are 
likely to explain the dimension of the outbreak.
After the initial cases presented here and as of the 
end of November 2012, the National Institute of Health 
laboratory tested an additional 43 samples by RT-PCR, 
28 of which were found positive. In all of these cases 
DEN-1 serotype was identified.
The circulation of the four serotypes of dengue in the 
Caribbean region and South America is described [8]. 
Hence as it has not yet been identified how the mos-
quito and the virus were introduced in Madeira, we can 
assume that there is a risk of new introductions, and 
spread of new virus serotypes in the next years. As it is 
well known, the absence of long-term cross-immunity 
among the different dengue serotypes allows for multi-
ple sequential infections with heterologous serotypes 
and the occurrence of cases with more severe disease.
Vector control and surveillance in the territory to 
avoid the mosquitos’ introduction to other regions of 
Madeira archipelago and to the mainland is necessary 
and has already been implemented by the local health 
authorities.
After 2012, the clinical cases should also be evalu-
ated and serotyped due to the risk of new virus 
introductions.
In cases of dengue outbreaks, the laboratory has an 
essential role for early detection and reporting of the 
first cases. This contributes to the decision to imple-
ment vector control measures. Laboratory tests are 
important for precise identification of the aetiological 
agent and to retrace its origin. The reference laboratory 
also provides a quality control for other laboratories 
and helps with the continuous monitoring of suspected 
cases
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